ClinicalTrials.gg
Drug

Apomorphine clinical trials

Also written APL-130277, KW-6500, Apokinon and APOKYN.

studies test it
38
open now
2
in phase 3
15
first study started
1999

How each study uses Apomorphine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Apomorphine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Apr 2004 · APOKYN · NDA 021264 (FDA, Drugs@FDA)
European Union
28 May 2001 · Uprima · EMEA/H/C/000327 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Apomorphine
14
apomorphine HCl injection
4
Apomorphine Hydrochloride, Sublingual Thin Film
3
Apomorphine Hydrochloride
3
Apomorphine hydroshloride (USAN)
3

Brand

Apokinon
2
APOKYN
2

Development codes

APL-130277
6
KW-6500
4

Studies by the year they started

38 studies that test it; most in 2017 (5)

Studies that test Apomorphine, by start year
YearStudies
19992
20012
20051
20061
20074
20093
20103
20122
20142
20154
20162
20175
20182
20191
20212
20222

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 2
16
Phase 3
15
Phase 4
6
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 19

Sumitomo Pharma America, Inc. (6) · Kyowa Kirin Co., Ltd. (4) · Mylan Bertek Pharmaceuticals (4) · MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals (3) · Rennes University Hospital (3) · Rambam Health Care Campus (2) · South Glasgow University Hospitals NHS Trust (2) · University of Liege (2)

Often tested with

Tested in the same studies.

Dopamine agonists (1) · Levodopa (1) · Hydrocortisone (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test Apomorphine, phase 3 first.

Studies

Open first, then newest update. How each study uses Apomorphine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 38

See all 38 studies that test Apomorphine →

Codes

What other systems call Apomorphine · ClinicalTrials.gg INT007016

  • MeSH (NLM) D001058ApomorphineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) N21FAR7B4SAPOMORPHINEConfirmed FDA, NLM, Wikidata
  • RxNorm 1043Confirmed FDA, Wikidata
  • Wikidata Q269111apomorphineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61639ApomorphineOne source FDA
  • DrugBank DB00714One source Wikidata

Also registered as apomorphine hydrochloride (UNII F39049Y068 · RxNorm 71225) and apomorphine hydrochloride anhydrous (UNII 9K13MD7A0D).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.